Patients currently undergoing immunosuppressive therapy (phototherapy, or concomitant application of other immunosuppressant agents) should not receive alefacept to avoid the risks of excessive immunosuppression.
Patients currently receiving immunosuppressive therapy (phototherapy or concurrent use of other immunosuppressants) should not receive alefacept to avoid the risks of excessive immunosuppression.